interleukin-8 and Uterine-Hemorrhage

interleukin-8 has been researched along with Uterine-Hemorrhage* in 1 studies

Reviews

1 review(s) available for interleukin-8 and Uterine-Hemorrhage

ArticleYear
Decidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding.
    Reproductive sciences (Thousand Oaks, Calif.), 2009, Volume: 16, Issue:2

    Factor VII binds trans-membrane tissue factor to initiate hemostasis by forming thrombin. Tissue factor expression is enhanced in decidualized human endometrial stromal cells during the luteal phase. Long-term progestin only contraceptives elicit: 1) abnormal uterine bleeding from fragile vessels at focal bleeding sites, 2) paradoxically high tissue factor expression at bleeding sites; 3) reduced endometrial blood flow promoting local hypoxia and enhancing reactive oxygen species levels; and 4) aberrant angiogenesis reflecting increased stromal cell-expressed vascular endothelial growth factor, decreased Angiopoietin-1 and increased endothelial cell-expressed Angiopoietin-2. Aberrantly high local vascular permeability enhances circulating factor VII to decidualized stromal cell-expressed tissue factor to generate excess thrombin. Hypoxia-thrombin interactions augment expression of vascular endothelial growth factor and interleukin-8 by stromal cells. Thrombin, vascular endothelial growth factor and interleukin-8 synergistically augment angiogenesis in a milieu of reactive oxygen species-induced endothelial cell activation. The resulting enhanced vessel fragility promotes abnormal uterine bleeding.

    Topics: Animals; Cell Hypoxia; Contraceptive Agents, Female; Decidua; Endometrium; Female; Hemostasis; Humans; Interleukin-8; Neovascularization, Physiologic; Progestins; Reactive Oxygen Species; Stromal Cells; Thrombin; Thromboplastin; Uterine Hemorrhage; Vascular Endothelial Growth Factor A

2009